Moonlight Therapeutics
PrivateLast Round
VC Round
Oct 16, 2025
Total Funding Raised
$17.56M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Moonlight Therapeutics is a biotechnology company developing a platform to treat food allergies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Moonlight Therapeutics Comparables
Compare Moonlight Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Intrommune Therapeutics | 87% | |
| Aravax | 80% | |
| IgGenix | 79% |
Moonlight Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 16, 2025 | ||||
| Series A | Sep 12, 2024 | ||||
| Grant | Oct 16, 2023 | ||||
| Grant | Oct 16, 2023 | ||||
| Grant | Jul 10, 2023 | ||||
Seed | Aug 30, 2021 |
Moonlight Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| AllerFund | Series A |
| Defense Health Agency | Grant |
| NIH RADx | Grant |
| SeedtoB Capital | Seed |
| Portal Innovations | Series A |
| SOSV | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 103% MoM, reaching 1.1K.
- Oct 16, 2025
Peanut allergy treatment MOON101 cleared for adult and child testing.
Moonlight Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Moonlight Therapeutics's valuation, stock price, and market status.
Is Moonlight Therapeutics a public or private company?
Moonlight Therapeutics is a private company.
What is the current stock price of Moonlight Therapeutics?
Moonlight Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Moonlight Therapeutics worth (valuation)?
Valuation information for Moonlight Therapeutics is not publicly available.
Can I buy Moonlight Therapeutics stock?
Moonlight Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Moonlight Therapeutics's last funding round?
Moonlight Therapeutics's most recent funding round was VC Round on October 16, 2025.
Who are the main investors in Moonlight Therapeutics?
Key investors in Moonlight Therapeutics include AllerFund, Portal Innovations.
Will Moonlight Therapeutics IPO soon?
No public IPO plans have been announced for Moonlight Therapeutics.
How can I track Moonlight Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Moonlight Therapeutics's secondary market activity and sign up for updates.